Position in ASND
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$6,932,319
-$1,567,516 QoQ
Shares Held
25,991
-30.1% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#110
of 308 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Diversified Trust Co holds $33,471,666 across 42 Biotechnology names. ASND ranks #1 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
This page
|
25,991 | $6,932,319 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
39,222 | $2,367,439 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
19,050 | $2,230,183 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
35,281 | $2,004,313 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,481 | $1,547,002 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
41,966 | $1,401,244 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
66,194 | $1,238,489 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
46,194 | $1,168,708 |
All Filings in ASND
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,932,319 | 25,991 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $8,499,835 | 37,161 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $9,009,603 | 42,251 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $9,081,839 | 45,681 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $7,839,146 | 45,418 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $7,254,971 | 46,548 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $6,200,381 | 45,038 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $6,259,672 | 41,924 | Shares | Sole | 2024-10-07 | |
| No filing history on record for this holder in this stock. | ||||||